Based in Cambridgeshire, Kymab is discovering and developing human monoclonal antibody therapeutics with an initial focus on malaria and HIV.
Led by CEO Simon Sturge, the pharmaceutical company has raised over £200m over seven funding rounds. Investors include LifeArc, Malin Corporation and ...
“I will tell you how to become rich. Close the doors. Be fearful when others are greedy. Be greedy when others are fearful.”
It's important to remember that the selling frenzy that has captivated Wall Street in recent weeks may not be over, and anyone who says they can time ...
Airbnb Inc. will be the 2020 blockbuster IPO offering.
While the IPO market is likely to remain steady next year, there will be fewer splashy listings coming to market, and premium valuations are going to ...
Satisfied Users & 
Approved Press Releases
